Journal · Hepatology · Updated 21 November 2026
Hepatology International
Read Hepatology International articles on DeepDyve. No university library needed.
Hepatology International has published since 2007 and covers liver disease, from hepatitis B guidelines and liver cancer across Asia to fatty liver disease, liver fibrosis and the critical care of acute-on-chronic liver failure. It’s an official journal of the Asian Pacific Association for the Study of the Liver, published by Springer Nature. A DeepDyve subscription lets you read it in full, alongside millions of articles from other journals licensed from publishers including Springer Nature.
Then $59 a month or $499 a year. A credit card is required; cancel during the trial and you won’t be charged. You read articles online; PDFs are sold separately.
Personal plans aren’t for business use. Reading for work? See Enterprise.
Hepatology International at a glance
- Full title
- Hepatology International
- Abbreviation (NLM)
- Hepatol Int
- Publisher
- Springer Nature
- Print ISSN
- 1936-0533
- Online ISSN (eISSN)
- 1936-0541
- First published
- 2007
- Subjects
- Gastroenterology
- Access model
- Hybrid (20% free to read in 2026)
Ways to access Hepatology International
20% of the articles Hepatology International published from January 1 to November 19, 2026 are open access and free to read. For the rest, look for the authors’ manuscript, check a library, or read them on DeepDyve.
- Open access articles. 20% of Hepatology International articles published from January 1 to November 19, 2026 carry a Creative Commons license, per Crossref, and are free to read. They’re marked “Open access” below.
- The authors’ accepted manuscript. For subscription articles, Springer Nature lets authors post their accepted manuscript on their own website as soon as it’s accepted, and in a repository such as PubMed Central 12 months after publication.
- Ask the authors. Authors can also share a free, read-only link to their published article through Springer Nature’s SharedIt, so it’s worth asking the authors directly.
- NIH-funded research. For papers accepted on or after July 1, 2025, the US National Institutes of Health requires the accepted manuscript in PubMed Central, free with no embargo from the official publication date.
- A library. Your university, hospital or public library may subscribe to Hepatology International. Check its journal list and whether it offers remote access.
- DeepDyve. Read Hepatology International articles online for $59 a month or $499 a year after a free first month. Articles marked LitStream below are in DeepDyve’s LitStream collection, which a subscription lets you read online. PDFs are sold separately, and availability varies by article.
Sources: Springer Nature self-archiving policy; NIH Public Access Policy; open access share from Crossref license data.
Impact factor and metrics
Hepatology International’s 2025 Journal Impact Factor is 7.8, and its 5-year Impact Factor is 7.1.
7.8
Journal Impact Factor (2025)
7.1
5-year Impact Factor (2025)
7 days
Median time to first decision
1.2M
Downloads (2025)
Source: journal metrics on the Hepatology International homepage (Springer Nature), checked November 21, 2026. Impact Factor from Clarivate Journal Citation Reports.
Recent Hepatology International research worth reading
Published January to July 2026. Summaries describe what the authors report.
-
APASL clinical practice guidelines on the management of chronic hepatitis B infection: a 2026 update
The APASL Viral Elimination Taskforce sets out updated clinical practice guidelines for chronic hepatitis B, with recommendations in 13 major areas covering screening, vaccination, treatment and liver cancer surveillance, aimed at practical and cost-effective decisions in the Asia Pacific region.
You et al. · Hepatology International, published online June 27, 2026 · DOI 10.1007/s12072-026-11108-1
-
Association of total and regional fat-to-muscle ratio with the risk of metabolic dysfunction-associated fatty liver disease and other chronic liver diseases
Following 356,833 UK Biobank participants for a median of 14.0 years, the authors report that a high fat-to-muscle ratio raised the risk of MASLD in both sexes (HR 2.29–2.76), while links to cirrhosis, liver death and liver cancer were seen mainly in men.
Xi et al. · Hepatology International, published online March 6, 2026 · DOI 10.1007/s12072-026-11064-w
-
Temporal trends and regional variations in hepatocellular carcinoma etiology: a multinational study across Asia
Analyzing 6,261 liver cancer patients from 19 centers in seven Asian countries and regions, the authors report that hepatitis B stayed the leading cause in many countries (43.3%–69.5%), while hepatitis C fell and fatty liver disease-related cases rose in Japan.
Takeuchi et al. · Hepatology International, published online February 5, 2026 · DOI 10.1007/s12072-026-11037-z
-
NAT10 promotes the activation of hepatic stellate cells by modulating the TGF-β1-ac4C-COL1A1 axis
The authors report that the RNA acetyltransferase NAT10 rises in fibrotic mouse livers and activated hepatic stellate cells, where it adds ac4C marks that stabilize TGFB1 and COL1A1 mRNA, forming a positive feedback loop with TGF-β1 that drives liver fibrosis.
Zhang et al. · Hepatology International, published online January 20, 2026 · DOI 10.1007/s12072-025-10998-x
-
A global consensus on the critical care management of acute-on-chronic liver failure patients: the APASL ACLF Beijing Position Paper
A global group of 109 experts presents 104 position statements on the intensive care of acute-on-chronic liver failure, covering prognostic scores for ICU decisions, organ support, antibiotics and fluids, bridging therapies, nutrition, and when to consider transplantation.
Chen et al. · Hepatology International, published online July 30, 2026 · DOI 10.1007/s12072-026-11116-1
Related journals
Questions about Hepatology International
How can I read Hepatology International articles without a subscription?
20% of Hepatology International articles published from January 1 to November 19, 2026 are open access and free to read. For subscription articles, Springer Nature lets authors post their accepted manuscript on their own website as soon as it’s accepted, and in a repository such as PubMed Central 12 months after publication. Your library may also subscribe. DeepDyve lets you read Hepatology International articles online for $59 a month or $499 a year after a free first month.
What is the abbreviation for Hepatology International?
Hepatology International’s NLM (PubMed) abbreviation is Hepatol Int.
What is the ISSN of Hepatology International?
The print ISSN is 1936-0533 and the online ISSN is 1936-0541.
What is the impact factor of Hepatology International?
Hepatology International’s Journal Impact Factor is 7.8 (2025), and its 5-year Impact Factor is 7.1, according to Springer Nature’s published metrics.
Is Hepatology International open access?
Hepatology International is a hybrid journal: most articles are published under the subscription model, and authors can choose to publish open access. From January 1 to November 19, 2026, 35 of 173 Hepatology International articles (20%) carry a Creative Commons license, per Crossref.
Hepatology International articles on DeepDyve are licensed from Springer Nature. Journal facts as of 21 November 2026.
Start reading Hepatology International today
One month free, then less than $2 a day. Hepatology International, plus millions of articles from thousands of journals.






